RU2015125313A - Вакцина для защиты жвачных животных от пневмонии, вызываемой pasteurella multocida - Google Patents
Вакцина для защиты жвачных животных от пневмонии, вызываемой pasteurella multocida Download PDFInfo
- Publication number
- RU2015125313A RU2015125313A RU2015125313A RU2015125313A RU2015125313A RU 2015125313 A RU2015125313 A RU 2015125313A RU 2015125313 A RU2015125313 A RU 2015125313A RU 2015125313 A RU2015125313 A RU 2015125313A RU 2015125313 A RU2015125313 A RU 2015125313A
- Authority
- RU
- Russia
- Prior art keywords
- vaccine
- virus
- bacteria
- multocida
- spraying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Claims (7)
1. Вакцина, включающая живые аттенуированные бактерии Pasteurella Multocida для защиты жвачных животных от пневмонии, вызываемой P. Multocida, при помощи введения вакцины в верхние отделы дыхательных путей жвачного животного путем распыления вакцины, отличающаяся тем, что введение имеет место в виде интраназального распыления.
2. Вакцина по п. 1, отличающаяся тем, что распыление обеспечивает аэрозоль частиц вакцины, имеющих средний размер менее 50 мкм в диаметре.
3. Вакцина по п. 2, отличающаяся тем, что средний размер частиц составляет от 20 до 40 мкм в диаметре.
4. Вакцина по любому из пп. 1-3, отличающаяся тем, что вакцина дополнительно включает живой аттенуированный вирус парагриппа-3 и живой аттенуированный респираторно-синцитиальный вирус крупного рогатого скота для защиты от респираторных заболеваний, вызываемых вирусом парагриппа и респираторно-синцитиальным вирусом.
5. Вакцина по п. 4, отличающаяся тем, что она включает живой аттенуированный вирус инфекционного ринотрахеита крупного рогатого скота для защиты от респираторных заболеваний, вызываемых вирусом инфекционного ринотрахеита крупного рогатого скота.
6. Применение аттенуированных бактерий Pasteurella Multocida для производства вакцины, которая при введении в верхние отделы дыхательных путей жвачного животного путем интраназального распыления вакцины обеспечивает защиту от пневмонии, вызываемой бактериями P. Multocida.
7. Способ защиты жвачных животных от пневмонии, вызываемой бактериями Pasteurella Multocida, включающий введение вакцины, включающей живые аттенуированные бактерии P. Multocida, в верхние отделы дыхательных путей жвачного животного путем интраназального распыления вакцины.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12194759 | 2012-11-29 | ||
| EP12194759.2 | 2012-11-29 | ||
| PCT/EP2013/074930 WO2014083091A1 (en) | 2012-11-29 | 2013-11-28 | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2015125313A true RU2015125313A (ru) | 2017-01-11 |
| RU2613672C2 RU2613672C2 (ru) | 2017-03-21 |
Family
ID=47226059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015125313A RU2613672C2 (ru) | 2012-11-29 | 2013-11-28 | Вакцина для защиты жвачных животных от пневмонии, вызываемой pasteurella multocida |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140147475A1 (ru) |
| EP (1) | EP2925354B1 (ru) |
| AU (1) | AU2013351213B2 (ru) |
| BR (1) | BR112015012274A2 (ru) |
| ES (1) | ES2676833T3 (ru) |
| MX (1) | MX356560B (ru) |
| RU (1) | RU2613672C2 (ru) |
| WO (1) | WO2014083091A1 (ru) |
| ZA (1) | ZA201503804B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
| PL2976102T3 (pl) | 2013-03-18 | 2020-05-18 | Intervet International B.V. | Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica |
| WO2015066292A1 (en) | 2013-11-01 | 2015-05-07 | Merial Limited | Attenuated pasteurella multocidavaccines & methods of making & use thereof |
| CN113046271B (zh) * | 2021-04-10 | 2022-10-14 | 福建省农业科学院畜牧兽医研究所 | 一株兔f型多杀性巴氏杆菌及其在制备灭活疫苗中的应用 |
| CN113855793A (zh) * | 2021-10-19 | 2021-12-31 | 西南大学 | 牛源a型多杀性巴氏杆菌基因缺失株的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132775A (en) | 1973-12-03 | 1979-01-02 | Richardson-Merrell Inc. | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same |
| US5256415A (en) | 1989-03-20 | 1993-10-26 | Louisiana State University | Vaccine against bovine respiratory disease (pasteurellosis) |
| EP0650734B1 (en) | 1993-10-28 | 1999-03-10 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Pentavalent live viral vaccine |
| EP0810283A3 (en) | 1996-05-31 | 1997-12-10 | Akzo Nobel N.V. | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
| FI20002217A (fi) | 1999-12-30 | 2001-07-01 | Orion Yhtymae Oyj | Inhalaatiopartikkelit |
| US7923023B2 (en) | 2002-02-25 | 2011-04-12 | Astech International LLC | Method and composition for delivery of medicants to animals |
| US7217420B2 (en) | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| OA12915A (en) | 2002-08-26 | 2006-10-13 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle. |
| US6830010B2 (en) * | 2002-10-22 | 2004-12-14 | Heartland Premium Beef, Inc. | Quality assurance program and method for meat production |
| SI1638598T1 (sl) * | 2003-07-02 | 2007-04-30 | Biotechnology Res & Dev | Acapsularna bakterija p. multocida mutanta z delecijo gena hyae |
| FR2862306B1 (fr) * | 2003-11-17 | 2008-05-30 | Aventis Pasteur | Composition vaccinale |
| WO2005077409A1 (en) | 2004-02-18 | 2005-08-25 | The University Of Newcastle Research Associates Limited | A vaccine formulated for administration to mucosa of the lungs |
| CA2591624A1 (en) | 2004-12-22 | 2006-11-23 | Intervet International B.V. | Pasteurella multocida vaccine |
| US20080241192A1 (en) | 2007-03-26 | 2008-10-02 | Wyeth | Vaccination against multiple serotypes of pasteurella multocida |
| US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
| PL2976102T3 (pl) | 2013-03-18 | 2020-05-18 | Intervet International B.V. | Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica |
-
2013
- 2013-11-26 US US14/090,178 patent/US20140147475A1/en not_active Abandoned
- 2013-11-28 BR BR112015012274A patent/BR112015012274A2/pt not_active Application Discontinuation
- 2013-11-28 US US14/647,337 patent/US9662382B2/en active Active
- 2013-11-28 RU RU2015125313A patent/RU2613672C2/ru not_active IP Right Cessation
- 2013-11-28 MX MX2015006797A patent/MX356560B/es active IP Right Grant
- 2013-11-28 ES ES13795795.7T patent/ES2676833T3/es active Active
- 2013-11-28 AU AU2013351213A patent/AU2013351213B2/en active Active
- 2013-11-28 EP EP13795795.7A patent/EP2925354B1/en active Active
- 2013-11-28 WO PCT/EP2013/074930 patent/WO2014083091A1/en active Application Filing
-
2015
- 2015-05-27 ZA ZA2015/03804A patent/ZA201503804B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2925354B1 (en) | 2018-06-06 |
| AU2013351213A1 (en) | 2015-05-21 |
| WO2014083091A1 (en) | 2014-06-05 |
| ES2676833T3 (es) | 2018-07-25 |
| MX2015006797A (es) | 2015-09-10 |
| US9662382B2 (en) | 2017-05-30 |
| AU2013351213B2 (en) | 2017-10-19 |
| RU2613672C2 (ru) | 2017-03-21 |
| US20150297704A1 (en) | 2015-10-22 |
| ZA201503804B (en) | 2019-01-30 |
| EP2925354A1 (en) | 2015-10-07 |
| US20140147475A1 (en) | 2014-05-29 |
| BR112015012274A2 (pt) | 2017-07-11 |
| MX356560B (es) | 2018-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015125313A (ru) | Вакцина для защиты жвачных животных от пневмонии, вызываемой pasteurella multocida | |
| PH12018500856A1 (en) | Respiratory syncytial virus vaccine | |
| CY1120605T1 (el) | Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης | |
| HK1227279A1 (zh) | 在斷奶之前對抗豬繁殖與呼吸綜合徵(prrs)病毒的有效疫苗接種 | |
| EP3344290A4 (en) | VACCINE BASED ON VIRUS-LIKE PARTICLES OF HUMAN RESPIRATORY SYNZYTIAL VIRUS (HRSV) | |
| EA201291306A1 (ru) | Состав сухого порошка, содержащий антимускариновое средство | |
| MX2013013906A (es) | Vacunas combinadas para prevencion de infecciones por virus porcino. | |
| IL222723A0 (en) | Respiratory syncytial virus antigenic compositions and methods | |
| EA033054B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| WO2011152804A3 (en) | Process for dry powder formulations | |
| MX2019007583A (es) | Vacuna de eimeria con una eficacia mejorada. | |
| WO2013036610A3 (en) | Compositions comprising mg53 and methods for the treatment and prevention of airway injury | |
| MX2012012915A (es) | Adherencia de inmunogeno y metodo para formar y utilizar el mismo. | |
| EP3630240A4 (en) | COMBINATION DEVICES, SYSTEMS AND METHODS FOR HUMIDIFYING THE AIRWAYS AND HIGHLY EFFICIENT DELIVERY OF PHARMACEUTICAL AEROSOLS | |
| MX364924B (es) | Inhalador de dosis medida mejorado. | |
| WO2015049519A3 (en) | Method and apparatus for making compositions for pulmonary administration | |
| EA201592018A1 (ru) | Фармацевтическая композиция, содержащая циклический пептид формулы x-gqretpegaeakpwy-xи применение для экстракорпоральной обработки легких | |
| MX2015013307A (es) | Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. | |
| MX2015011624A (es) | Composiciones farmaceuticas secas que comprenden nanoparticulas de agente activo ligadas a particulas portadoras. | |
| CN102845453A (zh) | 一种抑菌剂 | |
| EP2866792A4 (en) | MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM | |
| WO2015187918A3 (en) | Halogenated ether compounds and methods of inducing anesthesia | |
| CN105477278A (zh) | 治鸡眼的中药配方 | |
| WO2015027847A3 (zh) | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 | |
| CN105233670A (zh) | 一种光触媒伴侣 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20181129 |